Coleman John J, Peppin John F
US Drug Enforcement Administration (Retired), Fairfax, Virginia; President, DrugWatch International, Inc., Omaha, Nebraska.
University of Pikeville, College of Osteopathic Medicine, Pikeville, Kentucky; Marian University, College of Osteopathic Medicine, Indianapolis, Indiana. ORCID: https://orcid.org/0000-0002-7747-5384.
J Opioid Manag. 2023 Special-Issue;19(7):117-122. doi: 10.5055/jom.2023.0805.
Between 1999 and 2019, according to the Centers for Disease Control and Prevention (CDC), nearly 450,000 people died from overdoses involving prescribed opioids. This review examines how drug overdose deaths are compiled by the CDC using the coding system of the International Classification of Diseases (ICD). When it comes to drug-involved deaths, the ICD may not tell the whole story or even the right story. To learn why, the authors examined the CDC's source data and the standard death certificate. In fatal drug overdose cases, death certificates are issued often before the results of post-mortem toxicology are known by the certifier. The CDC believes that this delay in the death investigation process may account for errors when, for example, certifiers list ambiguous terms such as "suspected acute drug intoxication" or "possible drug overdose" as a cause of death. When incomplete data are coded according to the ICD, the error is passed along while potentially useful information is lost. The result may reflect accurately the annual total of drug-involved overdose deaths while obscuring the lethality of individual substances, consumed alone or in combination, which contributed to, or caused, drug-involved deaths. The true cause of most fatal drug overdoses-polysubstance abuse-often is lost in this process. A key objective of this paper is to describe the process used by the CDC to report drug-involved mortality and how the current iteration of the ICD may be ill-suited for this important task.
根据美国疾病控制与预防中心(CDC)的数据,在1999年至2019年期间,近45万人死于与处方阿片类药物有关的过量用药。本综述探讨了CDC如何使用国际疾病分类(ICD)的编码系统来汇编药物过量死亡数据。在涉及药物的死亡案例中,ICD可能无法完整呈现甚至无法正确呈现整个情况。为了解其中原因,作者研究了CDC的源数据和标准死亡证明。在致命的药物过量案例中,死亡证明往往在认证人员得知尸检毒理学结果之前就已开具。CDC认为,死亡调查过程中的这种延迟可能导致错误,例如,认证人员将“疑似急性药物中毒”或“可能的药物过量”等模糊术语列为死亡原因时。当根据ICD对不完整的数据进行编码时,错误会延续下去,而潜在有用的信息则会丢失。结果可能准确反映了每年与药物有关的过量死亡总数,但却掩盖了单独或混合使用导致或造成与药物有关死亡的个别物质的致死性。大多数致命药物过量的真正原因——多物质滥用——在这个过程中往往被忽略。本文的一个关键目标是描述CDC报告与药物有关的死亡率所采用的过程,以及ICD的当前版本可能如何不适用于这项重要任务。